INOD vs. TGTX
INOD (Innodata Inc.) and TGTX (TG Therapeutics, Inc.) are both stocks. INOD operates in Information Technology Services (Technology), while TGTX operates in Biotechnology (Healthcare). Over the past 10 years, INOD returned 38.32%/yr vs 24.71%/yr for TGTX. Their 0.13 correlation means their historical movements had little consistent relationship.
Performance
INOD vs. TGTX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, INOD achieves a 23.32% return, which is significantly lower than TGTX's 74.54% return. Over the past 10 years, INOD has outperformed TGTX with an annualized return of 38.32%, while TGTX has yielded a comparatively lower 24.71% annualized return.
INOD
- 1D
- 4.59%
- 1M
- -13.01%
- 6M
- 13.33%
- YTD
- 23.32%
- 1Y
- 14.44%
- 3Y*
- 68.26%
- 5Y*
- 55.82%
- 10Y*
- 38.32%
- ALL TIME*
- 11.60%
TGTX
- 1D
- -2.80%
- 1M
- -2.78%
- 6M
- 76.79%
- YTD
- 74.54%
- 1Y
- 46.56%
- 3Y*
- 70.54%
- 5Y*
- 8.26%
- 10Y*
- 24.71%
- ALL TIME*
- -7.87%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
INOD Innodata Inc. | $54.92M | $62.65M | $169.97M |
| $111.05M | $115.82M | $119.77M |
INOD vs. TGTX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
INOD Innodata Inc. | 23.32% | 28.92% | 385.50% | 174.54% | -49.92% | 11.70% | 364.91% | -24.00% | 10.29% | -44.49% |
TGTX TG Therapeutics, Inc. | 74.54% | -0.96% | 76.23% | 44.38% | -37.74% | -63.48% | 368.65% | 170.73% | -50.00% | 76.34% |
Correlation
The correlation between INOD and TGTX is 0.16, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.16 |
Correlation (3Y) Balances recent behavior with more history. | 0.25 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.23 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.18 |
Correlation (All Time) Calculated using the full available price history since May 3, 2010 | 0.13 |
The correlation between INOD and TGTX shifts across timeframes, from 0.13 (all time) to 0.25 (3 years), reflecting how their relationship changes across market environments.
Fundamentals
INOD:
$2.05B
TGTX:
$7.96B
INOD:
$1.11
TGTX:
$2.88
INOD:
56.66
TGTX:
18.04
INOD:
0.01
TGTX:
0.03
INOD:
7.86
TGTX:
11.90
INOD:
17.44
TGTX:
14.28
INOD:
$283.42M
TGTX:
$700.35M
INOD:
$76.88M
TGTX:
$581.54M
INOD:
$37.35M
TGTX:
$156.88M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
INOD vs. TGTX — Risk / Return Rank
INOD
TGTX
INOD vs. TGTX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Innodata Inc. (INOD) and TG Therapeutics, Inc. (TGTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| INOD | TGTX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.87 | ||
| Sortino ratioReturn per unit of downside risk | -0.36 | ||
| Omega ratioGain probability vs. loss probability | 1.14 | 1.21 | -0.07 |
| Calmar ratioReturn relative to maximum drawdown | 0.23 | 1.74 | -1.51 |
| Martin ratioReturn relative to average drawdown | 0.39 | 3.46 | -3.07 |
Loading charts...
Drawdowns
INOD vs. TGTX - Drawdown Comparison
The maximum INOD drawdown since its inception was -95.47%, roughly equal to the maximum TGTX drawdown of -99.52%. Use the drawdown chart below to compare losses from any high point for INOD and TGTX.
Loading charts...
Drawdown Indicators
| INOD | TGTX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.47% | -99.52% | +4.05% |
Max Drawdown (1Y)Largest decline over 1 year | -63.03% | -26.85% | -36.18% |
Max Drawdown (3Y)Largest decline over 3 years | -63.03% | -42.06% | -20.97% |
Max Drawdown (5Y)Largest decline over 5 years | -74.44% | -89.47% | +15.03% |
Max Drawdown (10Y)Largest decline over 10 years | -74.44% | -93.19% | +18.75% |
Current DrawdownCurrent decline from peak | -48.29% | -77.71% | +29.42% |
Average DrawdownAverage peak-to-trough decline | -59.99% | -91.31% | +31.32% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 37.98% | 13.66% | +24.32% |
Volatility
INOD vs. TGTX - Volatility Comparison
Innodata Inc. (INOD) has a higher volatility of 19.48% compared to TG Therapeutics, Inc. (TGTX) at 12.23%. This indicates that INOD's price experiences larger fluctuations and is considered to be riskier than TGTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| INOD | TGTX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 19.48% | 12.23% | +7.25% |
Volatility (6M)Calculated over the trailing 6-month period | 88.73% | 33.96% | +54.77% |
Volatility (1Y)Calculated over the trailing 1-year period | 122.07% | 47.22% | +74.85% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 107.26% | 87.68% | +19.58% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 89.72% | 86.71% | +3.01% |
Dividends
INOD vs. TGTX - Dividend Comparison
Neither INOD nor TGTX has paid dividends to shareholders.
Financials
INOD vs. TGTX - Financials Comparison
This section allows you to compare key financial metrics between Innodata Inc. and TG Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
INOD vs. TGTX - Profitability Comparison
INOD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Innodata Inc. reported a gross profit of 0.00 and revenue of 90.10M. Therefore, the gross margin over that period was 0.0%.
TGTX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, TG Therapeutics, Inc. reported a gross profit of 171.41M and revenue of 204.92M. Therefore, the gross margin over that period was 83.7%.
INOD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Innodata Inc. reported an operating income of 0.00 and revenue of 90.10M, resulting in an operating margin of 0.0%.
TGTX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, TG Therapeutics, Inc. reported an operating income of 34.80M and revenue of 204.92M, resulting in an operating margin of 17.0%.
INOD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Innodata Inc. reported a net income of 14.90M and revenue of 90.10M, resulting in a net margin of 16.5%.
TGTX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, TG Therapeutics, Inc. reported a net income of 19.78M and revenue of 204.92M, resulting in a net margin of 9.7%.
Frequently Asked Questions
INOD and TGTX have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
INOD has higher volatility (19.48%) compared to TGTX (12.23%). In terms of maximum drawdown, INOD dropped -95.47% vs TGTX's -99.52%.
TGTX currently has the higher Sharpe Ratio (0.99 vs 0.12), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for INOD and TGTX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer